COMPANY · NIPC 500736502

GENERIS – FARMACEUTICA, S.A.

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €128,881.33 across 2 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameGENERIS – FARMACEUTICA, S.A.
NIPC500736502

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by year
YearContractsContract value
20252€128,881.33
Contracted value by buyer
NameContractsContract value
Unidade Local Saúde de Braga, E.P.E.1€90,381.33
Unidade Local de Saúde de Lisboa Ocidental, E. P. E.1€38,500
Contracted value by place of performance
NameContractsContract value
Braga1€90,381.33
Lisboa1€38,500
Largest contracts
SubjectYearContract value
Aquisição de Artigos Farmacêuticos2025€90,381.33
Aquisição Urgente de Cinacalcet - Unidade Local de Saúde Lisboa Ocidental - Ano de 2025.2025€38,500

Who they competed with

In 1 contract with a list of competitors, the company took part and was awarded 1 (100%).

Companies with the most procedures in common
CompanyProcedures in common
GENERIS – FARMACEUTICA, S.A.1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents2 companies and 1 link. The list below gives the same content as text.NIPC 500736502 (NIPC 500736502)NIPC 500736502GENERIS – FARM… (NIPC 508107997)GENERIS – FARM…

Dotted: competed in the same procedure.

Investigations that mention it

No published investigation mentions this company by NIPC.